Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Real-time Estimate Cboe BZX 02:39:13 2024-05-13 pm EDT 5-day change 1st Jan Change
18.14 USD +5.50% Intraday chart for Walgreens Boots Alliance, Inc. +5.38% -30.34%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Equities Mixed Intraday as Markets Analyze Consumer Inflation Survey MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading MT
Increasing Short-Term Inflation Expectations Weigh on US Equity Indexes Ahead of Consumer, Producer Prices MT
US Equity Indexes Trade Mixed as Short-Term Inflation Expectations Increase MT
Walgreens Seeking Buyers for Boots Chain MT
Walgreens seeks out potential buyers for sale of its UK Boots pharmacy chain, Bloomberg reports RE
Walgreens Seeking Buyers for Boots Chain MT
Walgreens Seeking Buyers for Boots Chain MT
Walgreens Seeking Buyers for Boots Chain, Bloomberg Says MT
HSBC Adjusts Price Target on Walgreens Boots Alliance to $16 From $20 MT
Zebra Technologies first-quarter results beat estimates RE
CVS Omnicare staff in Las Vegas vote to join new union RE
Morgan Stanley Adjusts Price Target on Walgreens Boots Alliance to $16 From $20 MT
Walgreens Boots Alliance Keeps Quarterly Dividend at $0.25 Per Share, Payable June 12 to Shareholders of Record May 21 MT
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024 CI
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business CI
DoorDash Partners With WalGreens to Offer Payment Option for SNAP Customers in US MT
DoorDash and Walgreens Launch Unprecedented Access for SNAP Customers CI
Truist Securities Adjusts Price Target on Walgreens Boots Alliance to $20 From $25 MT
RBC Capital Cuts Walgreens Boots Alliance's Price Target to $22 From $26, Sector Perform Rating Kept MT
UBS Cuts Walgreens Boots Alliance's Price Target to $22 From $25, Maintains Neutral Rating MT
Economic Data Leave Equity Markets Mixed; Yields Surge MT
Economic Data Leave Equity Markets Mixed; Yields Surge MT
News Highlights : Top Company News of the Day - Thursday at 7 PM ET DJ
S&P closes higher to secure strongest Q1 since 2019 RE
Chart Walgreens Boots Alliance, Inc.
More charts
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
17.19 USD
Average target price
22.77 USD
Spread / Average Target
+32.46%
Consensus
  1. Stock Market
  2. Equities
  3. WBA Stock
  4. News Walgreens Boots Alliance, Inc.
  5. Walgreens Boots Alliance Names Tim Wentworth as Chief Executive
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW